Sanguine Biosciences
PrivateLast Round
Debt
Nov 1, 2023
Total Funding Raised
$10.22M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Sanguine Biosciences is a biotechnology company that provides a platform for direct-to-patient engagement and in-home collection of annotated biospecimens for research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sanguine Biosciences Comparables
Compare Sanguine Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CGT Global | 87% | |
| Audubon Bioscience | 85% | |
| ProteoGenex, Inc. | 85% | |
Sanguine Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Nov 1, 2023 | ||||
| VC Round | Jan 9, 2023 | ||||
| Grant | Feb 26, 2019 | ||||
| Seed | Mar 7, 2013 |
Key People
Founding team and executive leadership
Sanguine Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalio Capital Management | Debt |
| INVENT Ventures, Inc. | Seed |
| BroadOak Capital Partners | VC Round |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 207, 2.6x the trailing average.
- Jul 20, 2026
Open roles increased to 205, 12.1x the trailing average.
Sanguine Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sanguine Biosciences's valuation, stock price, and market status.